These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 22188797

  • 1. Efficacy and safety of bosentan in adults with simple and complex Eisenmenger's syndrome.
    Williams R, Houser L, Miner P, Aboulhosn J.
    Congenit Heart Dis; 2012; 7(1):12-5. PubMed ID: 22188797
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease.
    Diller GP, Dimopoulos K, Kaya MG, Harries C, Uebing A, Li W, Koltsida E, Gibbs JS, Gatzoulis MA.
    Heart; 2007 Aug; 93(8):974-6. PubMed ID: 17639112
    [Abstract] [Full Text] [Related]

  • 3. Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease.
    Baptista R, Castro G, da Silva AM, Monteiro P, Providência LA.
    Rev Port Cardiol; 2013 Feb; 32(2):123-9. PubMed ID: 23351920
    [Abstract] [Full Text] [Related]

  • 4. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M, Romeo E, Argiento P, Sarubbi B, Santoro G, Grimaldi N, Correra A, Scognamiglio G, Russo MG, Calabrò R.
    Int J Cardiol; 2012 Mar 22; 155(3):378-82. PubMed ID: 21081251
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study.
    Garg N, Tripathy N, Sinha N.
    Cardiol Young; 2011 Dec 22; 21(6):631-8. PubMed ID: 21729508
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
    Trojnarska O, Gwizdała A, Katarzyński S, Katarzyńska A, Szyszka A, Lanocha M, Grajek S, Kramer L.
    Cardiol J; 2009 Dec 22; 16(2):133-41. PubMed ID: 19387960
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome--a randomized, placebo-controlled, double-blind crossover study.
    Mukhopadhyay S, Nathani S, Yusuf J, Shrimal D, Tyagi S.
    Congenit Heart Dis; 2011 Dec 22; 6(5):424-31. PubMed ID: 21914136
    [Abstract] [Full Text] [Related]

  • 17. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study.
    Gatzoulis MA, Beghetti M, Galiè N, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M, BREATHE-5 Investigators.
    Int J Cardiol; 2008 Jun 23; 127(1):27-32. PubMed ID: 17658633
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.